Back
Dermata Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
DRMA
Dermata Therapeutics
Last Price:
1.10
Seasonality Move:
-57.39%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Dermata Therapeutics Price Quote
$1.10
-0.05 (-4.35%)
(Updated: November 22, 2024 at 12:55 PM ET)
Dermata Therapeutics Key Stats
Sell
20
Dermata Therapeutics (DRMA)
is a Sell
Day range:
$1.10 - $1.24
52-week range:
$1.05 - $13.35
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.5%
Volume:
77.5K
Avg. volume:
168.9K
1-year change:
-90.3%
Market cap:
$2.3M
Revenue:
$0
EPS:
$-21.41
How Much Does Dermata Therapeutics Make?
Data Unavailable
Is Dermata Therapeutics Growing As A Company?
Data Unavailable
Dermata Therapeutics Stock Price Performance
-
Did Dermata Therapeutics Stock Go Up Last Month?
Dermata Therapeutics share price went down by -26.28% last month -
Did DRMA's Share Price Rise Over The Last Year?
DRMA share price fell by -90.3% over the past 1 year
What Is Dermata Therapeutics 52-Week High & Low?
-
What Is Dermata Therapeutics’s 52-Week High Share Price?
Dermata Therapeutics has traded as high as $13.35 over the past 52 weeks -
What Is Dermata Therapeutics’s 52-Week Low Share Price?
Dermata Therapeutics has traded as low as $1.05 over the past 52 weeks
Dermata Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Dermata Therapeutics?
-
How Much Debt Does Dermata Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Dermata Therapeutics Have?
Cash and short term investments quarterly total is $6.1M -
What Is Dermata Therapeutics’s Book Value Per Share?
Book value per share is 2.83
Is Dermata Therapeutics Cash Flow Positive?
-
What Is DRMA Cash Flow From Operations?
Cash flow from operations (TTM) is -$9.4M -
What Is Dermata Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $8.9M -
What Is Dermata Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Dermata Therapeutics Return On Invested Capital
Data Unavailable
Dermata Therapeutics Earnings Date & Stock Price
-
What Is Dermata Therapeutics's Stock Price Today?
A single share of DRMA can be purchased today for 1.15 -
What Is Dermata Therapeutics’s Stock Symbol?
Dermata Therapeutics trades on the nasdaq under the ticker symbol: DRMA -
When Is Dermata Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Dermata Therapeutics is scheduled on November 22, 2024 -
When Is DRMA's next ex-dividend date?
Dermata Therapeutics's next ex-dividend date is November 22, 2024 -
How To Buy Dermata Therapeutics Stock?
You can buy Dermata Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Dermata Therapeutics Competitors
-
Who Are Dermata Therapeutics's Competitors?
Below is a list of companies who compete with Dermata Therapeutics or are related in some way:
Dermata Therapeutics Dividend Yield
-
What Is DRMA Dividend Yield?
Dermata Therapeutics’s dividend yield currently is 0% -
What Is Dermata Therapeutics’s Payout Ratio?
Dermata Therapeutics’s payout ratio is 0% -
When Did Dermata Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 22, 2024 -
What Is Dermata Therapeutics’s Dividend Per Share?
Dermata Therapeutics pays a dividend of $0.00 per share
Dermata Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 6.00 |
| Upside from Last Price: | 421.74% |